Knight Therapeutics
(TSX) GUD
Knight Therapeutics Financials at a Glance
Market Cap
$749.97M
Revenue (TTM)
$450.09M
Net Income (TTM)
$5.37M
EPS (TTM)
$-0.05
P/E Ratio
-142.99
Dividend
$0.00
Beta (Volatility)
0.44 (Low)
Dividend
$0.00
Beta (Volatility)
0.44 (Low)
Price
$7.56
Volume
13,096
Open
$7.65
Price
$7.56
Volume
13,096
Open
$7.65
Previous Close
$7.65
Daily Range
$7.56 - $7.65
52-Week Range
$5.50 - $7.74
Dividend
$0.00
Beta (Volatility)
0.44 (Low)
Price
$7.56
Volume
13,096
Open
$7.65
Previous Close
$7.65
Daily Range
$7.56 - $7.65
52-Week Range
$5.50 - $7.74
GUD News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Knight Therapeutics
Industry
Pharmaceuticals
Sector
Health CareEmployees
830
CEO
Samira Sakhia, MBA
Website
www.gud-knight.comHeadquarters
Montreal, QC H3Z 3B8, CA
GUD Financials
Key Financial Metrics (TTM)
Gross Margin
38%
Operating Margin
-1%
Net Income Margin
-1%
Return on Equity
-69%
Return on Capital
-0%
Return on Assets
-1%
Earnings Yield
-0.70%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$749.97M
Shares Outstanding
98.03M
Volume
13.10K
Short Interest
0.00%
Avg. Volume
105.09K
Financials (TTM)
Gross Profit
$150.74M
Operating Income
$2.20M
EBITDA
$54.37M
Operating Cash Flow
$70.30M
Capital Expenditure
$1.91M
Free Cash Flow
$68.40M
Cash & ST Invst.
$95.28M
Total Debt
$77.91M
Knight Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$133.11M
+37.4%
Gross Profit
$50.89M
+26.1%
Gross Margin
38.23%
N/A
Market Cap
$749.97M
N/A
Market Cap/Employee
$1.01M
N/A
Employees
745
N/A
Net Income
$8.85M
-17.5%
EBITDA
$21.29M
-12.4%
Quarterly Fundamentals
Net Cash
$17.37M
-85.9%
Accounts Receivable
$138.24M
+21.8%
Inventory
$135.87M
+32.3%
Long Term Debt
$57.78M
+97.0%
Short Term Debt
$20.13M
+0.0%
Return on Assets
-0.51%
N/A
Return on Invested Capital
-0.27%
N/A
Free Cash Flow
$33.80M
+8479.2%
Operating Cash Flow
$34.31M
+2235.4%